Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martin Rudnicki is active.

Publication


Featured researches published by Martin Rudnicki.


British Journal of Obstetrics and Gynaecology | 2009

A community-based long-term follow up of women undergoing obstetric fistula repair in rural Ethiopia.

Henriette Svarre Nielsen; L Lindberg; U Nygaard; H Aytenfisu; Ol Johnston; Bjarke Lund Sorensen; Martin Rudnicki; M Crangle; R Lawson; S Duffy

Objectives  To assess urinary and reproductive health and quality of life following surgical repair of obstetric fistula.


Neurourology and Urodynamics | 2009

Urodynamic assessment of anterior vaginal wall surgery: a randomized comparison between colporraphy and transvaginal mesh.

Marion Ek; Gunilla Tegerstedt; Christian Falconer; Anders Kjaeldgaard; Masoumeh Rezapour; Martin Rudnicki; Daniel Altman

To investigate the urodynamic effects of anterior vaginal wall prolapse surgery using either trocar guided transvaginal mesh or colporraphy.


British Journal of Obstetrics and Gynaecology | 2014

Anterior colporrhaphy compared with collagen‐coated transvaginal mesh for anterior vaginal wall prolapse: a randomised controlled trial

Martin Rudnicki; E Laurikainen; R Pogosean; I Kinne; Ulf Jakobsson; Pia Teleman

To investigate the anatomical cure rate and complications related to collagen‐coated mesh for cystocele, compared with a conventional anterior colporrhaphy.


British Journal of Obstetrics and Gynaecology | 2016

A 3–year follow‐up after anterior colporrhaphy compared with collagen‐coated transvaginal mesh for anterior vaginal wall prolapse: a randomised controlled trial

Martin Rudnicki; E Laurikainen; R Pogosean; I Kinne; Ulf Jakobsson; Pia Teleman

To compare the 1–year (previously published) and 3–year objective and subjective cure rates, and complications, related to the use of a collagen‐coated transvaginal mesh for anterior vaginal wall prolapse against a conventional anterior repair.


Acta Obstetricia et Gynecologica Scandinavica | 2017

Progesterone resistance in endometriosis: origins, consequences and interventions

Martin Rudnicki; Jie Yu; Yimin Shu; Robert N. Taylor

Endometriosis is a common cause of pelvic pain and affects up to 10% of women of reproductive age. Aberrant progesterone signaling in the endometrium plays a significant role in impaired decidualization and establishment of ectopic endometrial implants. Eutopic endometrial cells from women with endometriosis fail to downregulate genes needed for decidualization, such as those involved in cell cycle regulation, leading to unbridled proliferation. Several causes of progesterone resistance in the endometrium have been postulated, including congenital “preconditioning”, whereby the in utero environment renders infants susceptible to neonatal uterine bleeding and endometriosis. Progesterone action is crucial to decreasing inflammation in the endometrium, and deviant progesterone signaling results in a proinflammatory phenotype. Conversely, chronic inflammation can induce a progesterone‐resistant state. Repetitive retrograde endometrial shedding begets chronic peritoneal inflammation, which further exacerbates progesterone resistance. Genetic causes of progesterone resistance include progesterone receptor gene polymorphisms, altered microRNA expression, and epigenetic modifications to progesterone receptors and their targets. Environmental toxins such as dioxin play a possible role in the genesis of endometriosis by permitting an inflammatory milieu. A consequence of impaired progesterone action is that hormonal therapy is rendered ineffective for a subset of women with endometriosis. Synthetic progestins, such as dienogest, may overcome this phenomenon by increasing progesterone receptor expression and decreasing proinflammatory cytokines. Other modalities include high dose depot formulations of progestins, medicated intrauterine devices and the likely advent of oral GnRH antagonists. Unearthing root causes of progesterone inaction in endometriosis will aid in the development of novel therapeutics geared toward prevention and treatment.


Journal of Medical Case Reports | 2014

A novel DICER1 mutation identified in a female with ovarian Sertoli-Leydig cell tumor and multinodular goiter: a case report

Maria Rossing; Anne-Marie Gerdes; Anders Juul; Catherine Rechnitzer; Martin Rudnicki; Finn Cilius Nielsen; Thomas vO Hansen

IntroductionGerm-line mutations in the micro-ribonucleic acid processing gene DICER1 have been shown to predispose to a subset of benign tumors susceptible to malignant transformation, including ovarian Sertoli-Leydig cell tumor, nontoxic multinodular goiter, multilocular cystic nephroma and pleuropulmonary blastoma, which can occur in children and young adults. This may be due to reduced Dcr-1 homolog expression in carriers of germline mutations, which causes impairment of micro-ribonucleic acid processing and deregulates the growth and differentiation of target cells, leading to an increased risk of tumorigenesis. Many carriers of germ-line DICER1 mutations remain unaffected, but development of tumors within carriers is associated with varying prognoses.Case presentationDespite the Dcr-1 homolog syndrome phenotype being incompletely defined, a DICER1 mutation was suspected when a girl (case 1 patient) of Danish ethnicity presented with both an ovarian Sertoli-Leydig cell tumor and a multinodular goiter at the age of 13 years. In addition, family history included a male sibling (case 2 patient) who also had a multinodular goiter and had undergone a hemithyroidectomy at the age of 14 years. Subsequent DICER1 screening of the girl identified two novel mutations in exon 21 - a nonsense (c.3647C>A, p.Ser1216*) and a missense (c.3649T>A, p.Tyr1217Asn) mutation. The siblings had inherited the mutations from their father and paternal grandfather, which both currently were asymptomatic, indicating reduced penetrance of the nonsense mutation. Analysis of the parents revealed that the mutations were present in cis, making the contribution of the missense mutation less significant.ConclusionWe report a novel pathogenic DICER1 mutation (p.Ser1216*) in a Danish family associated with ovarian Sertoli-Leydig cell tumor and a multinodular goiter. A multinodular goiter was diagnosed in the siblings during childhood. Clinicians should be aware of a potential germ-line DICER1 mutation when evaluating multinodular goiter in young patients with or without a family history of thyroid diseases.


Acta Obstetricia et Gynecologica Scandinavica | 2017

Prevalence of urinary incontinence among women and analysis of potential risk factors in Germany and Denmark

Louise Schreiber Pedersen; Gunnar Lose; Mette Terp Høybye; Susanne Elsner; Annika Waldmann; Martin Rudnicki

Urinary incontinence (UI) is a prevalent condition that interferes with womens health‐related quality of life. Prevalence rates from earlier studies are wide‐ranging, due to heterogeneity in methodology, definition of UI and the populations included. We aimed to determine the prevalence of UI and associated risk factors in Germany and Denmark using the same methodology, definition and population.


Journal of Minimally Invasive Gynecology | 2012

Clinical Outcome after Hydrothermal Ablation Treatment of Menorrhagia in Patients with and without Submucous Myomas

Elise Hachmann-Nielsen; Martin Rudnicki

STUDY OBJECTIVE To analyze the long-term efficacy of hydrothermal ablation (HTA) in women with a normal uterine cavity and submucous uterine myomas. DESIGN Retrospective study (Canadian Task Force classification II-2). SETTING Roskilde University Hospital surgical daycare unit. PATIENTS One hundred sixty-six consecutive patients with abnormal uterine bleeding who underwent HTA from 2004 to 2008. All patients were asked to fill out a specific questionnaire that included questions related to postoperative bleeding patterns, complications, and satisfaction with the procedure. One hundred thirty-six patients (81.9%) completed the questionnaire, including 33 women (24.3%) with submucous myomas. INTERVENTION The HTA procedure was performed in accordance with previous descriptions. MEASUREMENTS AND MAIN RESULTS Mean (SD; 95% CI) follow-up was 33 (10.5; 25.5-31.8) months. Amenorrhea was achieved in 57 women with myomas (55.3%) and 17 women (51.5%) without myomas (p = .47). Postoperative light bleeding was reported in 26 women with myomas (25.2%) and 6 women (18.2%) without myomas. During follow-up, 13 women with myomas (12.6%) underwent hysterectomy, compared with 6 women without myomas (18.2%). Postoperatively, the mean (SD; 95% CI) number of days per month with bleeding was reduced in both groups, from 13.62 (7.90; 11.87-15.37) to 1.34 (2.32; 0.84-1.84) days in the group with myomas, and from 14.78 (8.81; 10.97-18.59), to 1.88 (4.38; 0.12-3.65) without myomas. Similarly, both groups reported improved quality of life: 74.8% and 72.7%, respectively (p = .59). Compared with patients with myomas 3 cm or smaller, patients with myomas larger than 3 cm demonstrated a significantly higher rate of severe bleeding postoperatively (p = .02). CONCLUSION Our results demonstrate that HTA is associated with a high rate of amenorrhea in patients with or without submucous myomas. However, a significantly lower effect may be observed in patients with myomas larger than 3 cm.


International Urogynecology Journal | 2007

Biomesh (Pelvicol®) erosion following repair of anterior vaginal wall prolapse

Martin Rudnicki

Sparse information is available regarding erosion following biomesh implantation. We report two cases of erosion following anterior vaginal wall repair. In both cases, the operation was performed as a standard cystocele repair where the collagen Pelvicol® mesh was anchored to the pubocervical fascia. Both patients had signs of erosion shortly after the operation, and both had the mesh removed. In one patient, the vaginal epithelium healed spontaneously, whereas the other patient had a delayed healing process. The graft was rejected due to intolerance to the biomesh or an infection. Our study shows that an erosion following implantation of a biomesh may be complicated.


Acta Obstetricia et Gynecologica Scandinavica | 2016

Laparoscopic surgery for early endometrial cancer

Gitte Bennich; Martin Rudnicki; Pernille Danneskiold Lassen

The purpose of the present study was to evaluate learning curves and short‐term outcomes following laparoscopic surgery for early endometrial cancer in women of different body mass index (BMI) classes.

Collaboration


Dive into the Martin Rudnicki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gunnar Lose

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E Laurikainen

Turku University Hospital

View shared research outputs
Top Co-Authors

Avatar

I Kinne

Akershus University Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge